Raleigh pharma quadruples revenue, lands new contract

Raleigh's BioDelivery Sciences International quadrupled revenue in 2017 and landed a new contract with Humana after reacquiring pain management drug Belbuca from Endo Pharmaceuticals at the beginning of last year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.